Dr Christy Goldsmith, Consultant Clinical Oncologist
Dr Christy Goldsmith
Consultant Clinical Oncologist
Dr Christy Goldsmith MBBS BSc MRCP FRCR MD(Res)
Consultant Clinical Oncologist
Dr Christy Goldsmith
Consultant Clinical Oncologist MBBS BSc MRCP FRCR MD(Res)
Dr Goldsmith is a Consultant Clinical Oncologist
Areas of expertise
- Breast cancer
- Clinical oncology
- Radiotherapy
Make an appointment
Address
-
Private Care at Guy’s at London Bridge Hospital
Guy's Cancer Centre, Great Maze Pond, London, SE1 9RT
-
London Radiotherapy Centre
Borough Wing, Lower Ground Floor, Guy’s Hospital, London, SE1 9RT
-
London Bridge Hospital
27 Tooley Street, London, SE1 2PR
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
About Dr Christy Goldsmith
GMC number: 4533388
Year qualified: 1998
Place of primary qualification: University of London
Areas of expertise
- Breast cancer
- Clinical oncology
- Radiotherapy
Professional memberships
Articles by Dr Christy Goldsmith
Radiotherapy.
Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints.
CyberKnife Radiosurgery of Skull-base Tumors: A UK Center Experience.
Evaluation of CyberKnife® Fiducial Tracking Limitations to Assist Targeting Accuracy: A Phantom Study with Fiducial Displacement.
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
An effective deep-inspiration breath-hold radiotherapy technique for left-breast cancer: impact of post-mastectomy treatment, nodal coverage, and dose schedule on organs at risk.
Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?
Neuroendocrine tumour of the cystic duct: a case report and literature review.
